Palbociclib After CDK and Endocrine Therapy (PACE)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Erica L Mayer, MD MPH
Dana-Farber Cancer Institute
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
22 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Miami
Miami, Florida, United States
- Emory University - Winship Cancer Institute
Atlanta, Georgia, United States
- Northwestern University
Chicago, Illinois, United States
- Indiana University
Indianapolis, Indiana, United States
- the University of Kansas Cancer Center - North
Kansas City, Kansas, United States
- the University of Kansas Cancer Center - Overland Park
Overland Park, Kansas, United States
- the University of Kansas Cancer Center
Westwood, Kansas, United States
- University of Louisville
Louisville, Kentucky, United States
- Eastern Maine Medical Center
Bangor, Maine, United States
- Boston Medical Center
Boston, Massachusetts, United States
- Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- Dana-Farber at St. Elizabeth'S Medical Center
Brighton, Massachusetts, United States
- Df/bwcc at Milford Regional Medical Center
Milford, Massachusetts, United States
- Df/bwcc in Clinical Affiliation With South Shore Hospital
South Weymouth, Massachusetts, United States
- the University of Kansas Cancer Center - Lee'S Summit
Lee's Summit, Missouri, United States
- Washington University
St Louis, Missouri, United States
- Dana-Farber/new Hampshire Oncology-Hematology
Londonderry, New Hampshire, United States
- University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States
- University of Pennsylvania
Philadelphia, Pennsylvania, United States
- Vanderbilt University Medical Center
Nashville, Tennessee, United States
- Baylor University
Houston, Texas, United States
- Aurora Cancer Care
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 5 Sept 2017
- Primary completion
- 31 Dec 2022
- Completion
- 30 Jun 2026
- Last update posted
- 30 Sept 2025
- Registered enrollment
- 220
- Registry id
- NCT03147287
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.